June 13, 2026 07:30 ET | Source: Intellia Therapeutics, Inc. Data from HAELO Phase 3 clinical trial presented today in…
TALVEY® plus daratumumab with or without pomalidomide showed progression-free survival of up to 81.3% and overall survival of up to 89.2% at 24…
RIYADH, Saudi Arabia, June 12, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH) will use its…
ENGINEERING THE INFRASTRUCTURE LAYER BETWEEN BIOLOGY, PHARMACEUTICAL SCIENCE & DIGITAL CAPITAL FORT LAUDERDALE, Fla., June 12, 2026 (GLOBE NEWSWIRE) --…
Strong sales momentum: across the UK and Greece, the brands' first two markets.Over $1.5 million in sales: C-Scrub and C-Sept…
Toronto, Ontario, June 11, 2026 (GLOBE NEWSWIRE) -- LifeLabs is proud to announce that we have been named as one of…
HANOVER, Md., June 11, 2026 (GLOBE NEWSWIRE) -- Priority Partners, one of Maryland’s largest Medicaid managed care organizations, received the…
Jupiter, F.L., June 11, 2026 (GLOBE NEWSWIRE) -- Human Continuum Inc. (“HC” or “the Company”), a developer of platelet-derived and…
KNOXVILLE, TN, June 10, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (“SafeSpace Global” or the “Company”), a provider of AI-powered…
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), June 10, 2026, 11:00 pm CET / 5:00 pm ET…